In addition, various HSPs also possess an immunomodulatory activity, and this property has been exploited in immunotherapeutic approaches, including the development of HSP-based cancer vaccines and the use of HSP-peptide complexes to enhance tumor antigen presentation and the organism’s immune response. The gene discussed is HSP90B2P; the disease is neoplasm.